Rai Tatemitsu

ライタテミツ | Rai Tatemitsu

Affiliation and department：
Job title： Professor
Homepage URL (1)： http://www.tmd.ac.jp/grad/kid/kid-J.htm

Research field (1)： Nephrology

Research theme for competitive and other funds (4)：

2016 - 2018 WNKシグナル系の新規機能の探索と制御機構の解明
2012 - 2014 蛋白相互作用阻害による新規高血圧治療薬の開発
2010 - 2013 腎臓における新規の血圧調節機構WNK-NCCシグナル伝達系の解明
サルコペニアの発症・進展の分子病態の解明と新規治療法の開発

Papers (100)：

Yoshiaki Matsuura, Naohiro Nomura, Wakana Shoda, Takayasu Mori, Kiyoshi Isobe, Koichiro Susa, Fumiaki Ando, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida. Tacrolimus ameliorates the phenotypes of type 4 Bartter syndrome model mice through activation of sodium-potassium-2 chloride cotransporter and sodium-chloride cotransporter. Biochem. Biophys. Res. Commun. 2019. 517. 2. 364-368
Soichiro Suzuki, Shotaro Naito, Yoshiyuki Numasawa, Mizuho Asada, Norikazu Shoji, Moko Zeniya, Daiei Takahashi, Hidehiko Sato, Soichiro Iimori, Naohiro Nomura, et al. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient. Intern. Med. 2019. 58. 12. 1775-1779
Ohkubo Atsushi, Okado Tomokazu, Sakurasawa Takatoshi, Maeda Takuma, Itagaki Ayako, Yamamoto Hiroko, Miyamoto Satoko, Seshima Hiroshi, Kurashima Naoki, Mori Takayasu, et al. 重症筋無力症の治療における通常型および選択的血漿分離器を用いたトリプトファン固定化カラムによる免疫吸着の除去特性(Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis). Therapeutic Apheresis and Dialysis. 2019. 23. 3. 271-278
Tamami Fujiki, Fumiaki Ando, Kana Murakami, Kiyoshi Isobe, Takayasu Mori, Koichiro Susa, Naohiro Nomura, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida. Tolvaptan activates the Nrf2/HO-1 antioxidant pathway through PERK phosphorylation. Sci Rep. 2019. 9. 1. 9245-9245
Hiroaki Kikuchi, Emi Sasaki, Naohiro Nomura, Takayasu Mori, Yoji Andrew Minamishima, Yuki Yoshizaki, Naohiro Takahashi, Taisuke Furusho, Yohei Arai, Shintaro Mandai, et al. Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease. Kidney international. 2019. 95. 1. 123-137

ｍore...

MISC (7)：

ｍore...

Books (1)：

Current Decision Support
2019

Lectures and oral presentations (60)：

SGLT2 inhibitors : The nephrologist's view
(SGLT2 Expert Meeting in Ochanomizu 2019)
Recent topics on treatment of chronic kidney disease
(2019)
Tolvaptan Activates Nrf2/HO-1 Pathway Through PERK Phosphorylation
(2018)
WNK1 Regulates Skeletal Muscle Hypertrophy by Modulating Phosphorylation, Nuclear Localization, and Transcriptional Activity of FoxO4
(2018)
Amelioration of Renal Fibrosis and Tubulointerstitial Damage in Fat-1 Transgenic CKD Mice by Compensation of Decreased Omega-3 Fatty Acids in the Kidney
(2018)

ｍore...

Work history (4)：

2016/04/01 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Medical and Dental Sciences Systemic Organ Regulation Nephrology
2015/11/01 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Endowed Departments Department of Nephrology and Regional Health(ibaraki) Professor
2001/04/01 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Endowed Departments Department of Nephrology and Regional Health(ibaraki) Professor
1900/01/01 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Medical and Dental Sciences Systemic Organ Regulation Nephrology Associate Professor

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page